Piper Jaffray to Co-Host China Life Sciences Event in Shanghai

Piper Jaffray to Co-Host China Life Sciences Event in Shanghai

November 03, 2006

    SHANGHAI, China, Nov. 3 /Xinhua-PRNewswire/ -- Piper
Jaffray will host its first China Life Sciences Event on
Wednesday, Nov. 15 in Shanghai. The event is co-hosted by
O'Melveny & Myers LLP and Deloitte Touche. 

    The China Life Sciences Event, which showcases some of
the most innovative companies in the life sciences sector,
will provide investors and corporate executives a unique
venue in which to hear first-hand about prospects,
opportunities, risks and challenges in this growing
health-related market segment. 

    The conference agenda includes presentation topics
covering the growth of life sciences companies, attractive
opportunities for institutional investors, pertinent
considerations for companies in this sector and the
changing life sciences climate in China. 

    Keynote addresses will be presented by Gerald Chan,
chairman of the Morningside Group and Ren Dequan, former
deputy commissioner of the State Food and Drug
Administration (SFDA). Other presentations will highlight
perspectives from venture and private equity investors, an
analysis of the U.S. capital markets and updates from
biopharmaceutical and medical device company executives.
Additional topics will include: intellectual property
protection and enforcement, the regulatory approval
process, strategic alliances and strategies for mergers and
acquisitions. 

    Companies scheduled to participate in the China Life
Sciences Event include: Aura Partners, BioVeda Capital,
Bridge Pharmaceuticals, Capital BioChip, China Medipharm,
China Medical, ChongQing JingShan, Curis, Eli Lily,
Fidelity Ventures, Green Valley, Hutchinson MediPharma
Limited, IDG Technology Venture Investment, Lifetech
Scientific, Medsphere, Microport Medical Co., Ltd.,
Morningside Group, Otsuka China, Pfizer, Profex, SAIF
Partners, SIG Capital Limited, Simcere Pharmaceuticals,
Sinocro Partners Limited, Summit Life Sciences, Sunway
Biotech Co., Ltd., TongJiTang and WI Harper Group. 
    Company and investor participation in the China Life
Sciences Event is by invitation only. Piper Jaffray clients
interested in attending should contact their Piper Jaffray
representative. 

    About Piper Jaffray

    Piper Jaffray Companies is a leading, international
middle market investment bank and institutional securities
firm, serving the needs of middle market corporations,
private equity groups, public entities, nonprofit clients
and institutional investors.  Founded in 1895, Piper
Jaffray provides a comprehensive set of products and
services, including equity and debt capital markets
products; public finance services; mergers and acquisitions
advisory services; high-yield and structured products;
institutional equity and fixed-income sales and trading;
and equity and high-yield research.  With headquarters in
Minneapolis, Piper Jaffray has 25 offices across the United
States and international locations in London, Madrid and
Shanghai.  The firm's UK operating subsidiary, Piper
Jaffray Ltd., is authorized and regulated by the Financial
Services Authority and is a member of the London Stock
Exchange. Piper Jaffray & Co. is the firm's principal
operating subsidiary.  (NYSE: PJC) (
http://www.piperjaffray.com )

    Since 1895. Member SIPC and NYSE.

    For more information, please contact:

     Susan Beatty 
     Media Relations, of Piper Jaffray
     Tel:   [phone] 
     Email: [e-mail]      

SOURCE  Piper Jaffray